Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 42:889-894, doi:10.1016/S0735-1097(03)00854-4
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sorajja, P.
Right arrow Articles by Holmes, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sorajja, P.
Right arrow Articles by Holmes, D. R., Jr

CLINICAL STUDY

Myocardial bridging in adult patients with hypertrophic cardiomyopathy

Paul Sorajja, MD*, Steve R. Ommen, MD*,*, Rick A. Nishimura, MD*, Bernard J. Gersh, MB, ChB, DPhil*, A. Jamil Tajik, MD* and David R. Holmes, Jr, MD*

* Division of Cardiovascular Disease and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA

Manuscript received January 21, 2003; revised manuscript received May 2, 2003, accepted May 13, 2003.

* Reprint requests and correspondence: Dr. Steve R. Ommen, Mayo Clinic, 200 SW First Street, Rochester, Minnesota 55905, USA.
ommen.steve{at}mayo.edu

OBJECTIVES: This investigation examined the risk of sudden cardiac death and other mortality in adult patients with hypertrophic cardiomyopathy (HCM) who have myocardial bridging diagnosed at coronary angiography.

BACKGROUND: Several reports have associated myocardial bridging with an adverse prognosis in pediatric HCM patients, but the prognosis of myocardial bridging in adult patients with HCM is unknown.

METHODS: The coronary angiograms of 425 patients with HCM (mean age 60 ± 15 years [range 18 to 89 years]) at the Mayo Clinic were examined for the presence of myocardial bridging. Clinical follow-up was conducted to assess mortality. Survival of patients with bridging was compared with HCM patients who also underwent angiography but who did not have evidence of bridging.

RESULTS: A total of 64 patients (15%) had myocardial bridging. The mean follow-up for the entire study was 6.8 ± 5.4 years. There was no difference in survival free of all-cause mortality (5-year estimate, bridging vs. no bridging, 91% vs. 85%; p = 0.42), all cardiac death (93% vs. 89%; p = 0.60), and sudden cardiac death (95% vs. 97%; p = 0.72). Univariate and multivariate proportional hazards models also did not identify the presence of bridging or specific characteristics of the degree or extent of bridging with a poor outcome.

CONCLUSIONS: This study observed no increased risk of death, including sudden cardiac death, among adult patients with HCM who had myocardial bridging diagnosed at coronary angiography.

Abbreviations and Acronyms
  CI = confidence interval
  HCM = hypertrophic cardiomyopathy
  ICD = implantable cardioverter-defibrillator
  LAD = left anterior descending coronary artery
  SCD = sudden cardiac death
  SM = septal myectomy




This article has been cited by other articles:


Home page
Eur Heart JHome page
C. Basso, G. Thiene, S. Mackey-Bojack, A. C. Frigo, D. Corrado, and B. J. Maron
Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death
Eur. Heart J., July 1, 2009; 30(13): 1627 - 1634.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
I. Olivotto, F. Cecchi, and M. H. Yacoub
Myocardial bridging and sudden death in hypertrophic cardiomyopathy: Salome drops another veil
Eur. Heart J., July 1, 2009; 30(13): 1549 - 1550.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
T. Hazirolan, M. Canyigit, M. Karcaaltincaba, M. G. Dagoglu, D. Akata, K. Aytemir, and A. Besim
Myocardial Bridging on MDCT
Am. J. Roentgenol., April 1, 2007; 188(4): 1074 - 1080.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Konen, O. Goitein, L. Sternik, Y. Eshet, J. Shemesh, and E. Di Segni
The Prevalence and Anatomical Patterns of Intramuscular Coronary Arteries: A Coronary Computed Tomography Angiographic Study
J. Am. Coll. Cardiol., February 6, 2007; 49(5): 587 - 593.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
E Ghersin, J Lessick, D Litmanovich, A Engel, and S Reisner
Comprehensive multidetector CT assessment of apical hypertrophic cardiomyopathy
Br. J. Radiol., December 1, 2006; 79(948): e200 - e204.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. R. Alegria, J. Herrmann, D. R. Holmes Jr, A. Lerman, and C. S. Rihal
Myocardial bridging
Eur. Heart J., June 2, 2005; 26(12): 1159 - 1168.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. A. Mohiddin and L. Fananapazir
Myocardial bridging in adult and pediatric patients with hypertrophic cardiomyopathy is not associated with poor outcome
J. Am. Coll. Cardiol., March 17, 2004; 43(6): 1133 - 1133.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Sorajja and S. R. Ommen
Reply
J. Am. Coll. Cardiol., March 17, 2004; 43(6): 1133 - 1133.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement